Using epidemiologic principles to design outcomes assessments

Formulary

Volumn 35, Issue 9, 2000, Pages 765-769

  Johnson, N ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR;

ARTICLE; DRUG FORMULARY; EPIDEMIOLOGICAL DATA; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; INCIDENCE; PREVALENCE; RISK ASSESSMENT;

EID: 0033824731     PISSN: 1082801X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Selecting patient factors for risk adjustment in health outcomes assessments
2. Randomized, controlled trials, observational studies, and the hierarchy of research designs
3. A comparison of observational studies and randomized, controlled trials
4. Convincing quasi-experiments: The interrupted time series and regression-discontinuity designs
5. Association between nonsteroidal anti-inflammatory drugs and upper gastrointestinal track bleeding/perforation: An overview of epidemiologic studies published in the 1990s
6. Outcomes studies of drug induced ulcer complications: Do we need them and how should they be done?
7. Peptic ulcer and gastrointestinal hemorrhage associated with non-steroidal anti-inflammatory drug use in patients younger than 65 years. A large health maintenance organization cohort study
8. What is pharmacoepidemiology?